Janet Englund, MD
Disclosures: Supported/contracted research-Gilead|Supported/contracted research-GlaxoSmithKline|Consultant fees-Sanofi-Aventis|Supported/contracted research-Chimerix|Supported/contracted research-Pfizer, Inc. - 02/26/2018

Janet A. Englund, MD                                                                                                    January 2023

Professor of Pediatrics, University of Washington

Director, Pediatric Transplant Infectious Diseases, Seattle Children’s Hospital


Dr. Englund’s research interests include the study of vaccines and viral respiratory diseases in children, pregnant women, and immunocompromised hosts. She studies respiratory viral vaccines and novel methods of antiviral therapy for respiratory viruses including influenza, RSV, and SARS-CoV-2. As a Clinical Associate at Fred Hutchinson Cancer Research Center, she is actively involved in studies of the prevention, treatment, and outcome of respiratory viral diseases in immunocompromised hosts. Dr. Englund’s research group at Seattle Children’s Hospital Research Institute is part of the New Vaccine Surveillance Network of the CDC, which assesses vaccine effectiveness of licensed vaccines in population-based studies.


Dr. Englund has been a member of national and international organizations including the CDC-sponsored Advisory Committee on Immunization Practices (ACIP), the FDA Vaccines and Related Biological Products Advisory Committee (VRBAC), and vaccine safety groups at the World Health Organization.



Janet Englund, MD

4500 Sand Point Way NE

Seattle, WA   98105